MedTrace Logo

Cranberry Ingestion and Cycling Related Immunity and Inflammation

NCT05407701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2023-01-26

No results posted yet for this study

Summary

This is a randomized, crossover clinical trial with 25 male and female cyclists. Study participants will ingest polyphenol-rich cranberry juice or placebo juice for 4 weeks under double-blinded procedures, and then crossover to the opposite supplement. The primary objective of this study is to examine the efficacy of 4-weeks ingestion of cranberry juice in moderating exercise-induced inflammation, immune dysfunction, and muscle damage. Outcome measures will include global proteiomics, oxylipins, and cytokines.

Conditions

  • Inflammatory Response
  • Metabolic Disturbance
  • Immune Suppression

Interventions

DIETARY_SUPPLEMENT

Cranberry Juice

100% cranberry juice

DIETARY_SUPPLEMENT

Placebo

Placebo juice

Sponsors & Collaborators

  • Ocean Spray, Inc.

    collaborator INDUSTRY

  • Appalachian State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-11-15
Completion
2023-01-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05407701 on ClinicalTrials.gov